title: Effects of cyproterone acetate, LHRH agonist and ovarian surgery in McCune-Albright syndrome with precocious puberty and galactorrhea.
abstract: We have studied the endocrinological pattern in a girl with McCune-Albright syndrome. The young patient showed: normal prepubertal serum levels of gonadotropins, fluctuating estrogen concentrations, which sometimes were similar to the levels in adult women of fertile age, hyperprolactinemia with galactorrhea, ovarian cysts. The effects of treatment with antiandrogen drug, cyproterone acetate, and of a LHRH agonist, buserelin (less than D-Ser[TBU(8)6-des-gly NH2.10 greater than LHRH ethylamide), were studied. Cyproterone acetate with or without buserelin did not fully suppress estradiol concentrations. On the other hand, surgical resection of these cysts resulted in both clinical and endocrinological remission. It is likely that in this case of McCune-Albright syndrome precocious puberty was a result of ovarian estrogen secretion, while pubertal activation of the hypothalamus-pituitary axis was absent. Hyperprolactinemia, which appeared after the beginning of the combined therapy with buserelin and cyproterone acetate, was probably due to the elevated estrogen levels.
authors.affiliation: Department of Endocrinology, University of Modena, Italy.
authors.forename: C
authors.initials: C
authors.lastname: Carani
authors.forename: C
authors.initials: C
authors.lastname: Pacchioni
authors.forename: A
authors.initials: A
authors.lastname: Baldini
authors.forename: D
authors.initials: D
authors.lastname: Zini
mesh_terms: D002064:Buserelin / Q000627:therapeutic use*; D002675:Child, Preschool; D003534:Cyproterone / Q000031:analogs & derivatives* / Q000627:therapeutic use; D017373:Cyproterone Acetate; D004958:Estradiol / Q000097:blood; D004967:Estrogens / Q000096:biosynthesis; D005260:Female; D005357:Fibrous Dysplasia of Bone / Q000628:therapy*; D005359:Fibrous Dysplasia, Polyostotic / Q000150:complications / Q000628:therapy*; D005640:Follicle Stimulating Hormone / Q000097:blood; D005687:Galactorrhea / Q000150:complications / Q000628:therapy*; D007987:Gonadotropin-Releasing Hormone / Q000037:antagonists & inhibitors*; D006801:Humans; D007775:Lactation Disorders / Q000628:therapy*; D007986:Luteinizing Hormone / Q000097:blood; D010053:Ovary / Q000503:physiopathology / Q000601:surgery*; D011388:Prolactin / Q000097:blood; D011629:Puberty, Precocious / Q000150:complications / Q000628:therapy*
chemical_list: D004967:Estrogens; D007987:Gonadotropin-Releasing Hormone; D017373:Cyproterone Acetate; D004958:Estradiol; D011388:Prolactin; D007986:Luteinizing Hormone; D005640:Follicle Stimulating Hormone; D003534:Cyproterone; D002064:Buserelin